Jingjing Pharmaceutical: Announcement of Resolutions of the 14th Meeting of the 6th Board of Directors
Securities code: 002349 Securities abbreviation: Jingjing Pharmaceutical Announcement number: 2026-025
Jingjing Pharmaceutical Group Co., Ltd.
Announcement of Resolutions of the 14th Meeting of the 6th Board of Directors
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete, and contains no false records, misleading statements or major omissions.
The notice of the 14th meeting of the 6th Board of Directors of Jingjing Pharmaceutical Group Co., Ltd. (hereinafter referred to as the "Company") was issued by fax, personal delivery, email, etc. on July 22, 2026. The meeting was held on July 24, 2026 (Friday) in the company's conference room by on-site and communication means. Nine directors should be present at the meeting, and 9 directors actually attended. The company's board secretary and other senior managers attended the meeting as non-voting delegates. The meeting was held in compliance with the relevant provisions of the Company Law of the People's Republic of China and the Articles of Association. The convening and convening of the meeting were legal and valid. The meeting was chaired by Chairman Yin Hongyu.
The following proposals were considered at this meeting:
- Considered and approved the "Proposal on Appointment of Financial Manager"
For details, please refer to the "Announcement on the Appointment of the Financial Personnel" on the same day in China Securities Journal and Juchao Information Network (www.cninfo.com.cn).
This proposal has been reviewed and approved by the Nomination Committee and Audit Committee of the Company's Board of Directors.
Voting results: 9 votes in favor; 0 abstentions; 0 votes against.
Announcement is hereby made.
Board of Directors of Jingjing Pharmaceutical Group Co., Ltd.
July 25, 2026